Research productivity and collaboration of the NIH-funded HIV vaccine trials network: A bibliometric analysis

by Jonathan Nye, M. Patricia D'Souza, Dale Hu, Dolan Ghosh
Published 2021-01-01

P15-19. Evaluating community engagement efforts in a large, multi-site, global HIV vaccine trials network

by None A, Maclachlan E, Broder G, Maggard K
Published 2009-10-01

Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054).

by Laurence Peiperl, Cecilia Morgan, Zoe Moodie, Hongli Li, Nina Russell, Barney S Graham, Georgia D Tomaras, Stephen C De Rosa, M Juliana McElrath, NIAID HIV Vaccine Trials Network
Published 2010-10-01

Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trial.

by Beryl A Koblin, Martin Casapia, Cecilia Morgan, Li Qin, Zhixue Maggie Wang, Olivier D Defawe, Lindsey Baden, Paul Goepfert, Georgia D Tomaras, David C Montefiori, M Juliana McElrath, Lilian Saavedra, Chuen-Yen Lau, Barney S Graham, NIAID HIV Vaccine Trials Network
Published 2011-01-01

Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults.

by Spyros A Kalams, Scott Parker, Xia Jin, Marnie Elizaga, Barbara Metch, Maggie Wang, John Hural, Michael Lubeck, John Eldridge, Massimo Cardinali, William A Blattner, Magda Sobieszczyk, Vinai Suriyanon, Artur Kalichman, David B Weiner, Lindsey R Baden, NIAID HIV Vaccine Trials Network
Published 2012-01-01

Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia...

by Susan P Buchbinder, Nicole A Grunenberg, Brittany J Sanchez, Kelly E Seaton, Guido Ferrari, M Anthony Moody, Nicole Frahm, David C Montefiori, Christine M Hay, Paul A Goepfert, Lindsey R Baden, Harriet L Robinson, Xuesong Yu, Peter B Gilbert, M Juliana McElrath, Yunda Huang, Georgia D Tomaras, HIV Vaccine Trials Network (HVTN) 094 Study Group
Published 2017-01-01

Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine i...

by Marnie L Elizaga, Shuying S Li, Nidhi K Kochar, Gregory J Wilson, Mary A Allen, Hong Van N Tieu, Ian Frank, Magdalena E Sobieszczyk, Kristen W Cohen, Brittany Sanchez, Theresa E Latham, David K Clarke, Michael A Egan, John H Eldridge, Drew Hannaman, Rong Xu, Ayuko Ota-Setlik, M Juliana McElrath, Christine Mhorag Hay, NIAID HIV Vaccine Trials Network (HVTN) 087 Study Team
Published 2018-01-01

Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adult...

by Kenneth H Mayer, Kelly E Seaton, Yunda Huang, Nicole Grunenberg, Abby Isaacs, Mary Allen, Julie E Ledgerwood, Ian Frank, Magdalena E Sobieszczyk, Lindsey R Baden, Benigno Rodriguez, Hong Van Tieu, Georgia D Tomaras, Aaron Deal, Derrick Goodman, Robert T Bailer, Guido Ferrari, Ryan Jensen, John Hural, Barney S Graham, John R Mascola, Lawrence Corey, David C Montefiori, HVTN 104 Protocol Team, and the NIAID HIV Vaccine Trials Network
Published 2017-11-01

Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP^® DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults

by Srilatha Edupuganti, Stephen C. De Rosa, Marnie Elizaga, Yiwen Lu, Xue Han, Yunda Huang, Edith Swann, Laura Polakowski, Spyros A. Kalams, Michael Keefer, Janine Maenza, Megan C. Wise, Jian Yan, Matthew P. Morrow, Amir S. Khan, Jean D. Boyer, Laurent Humeau, Scott White, Niranjan Y. Sardesai, Mark L. Bagarazzi, Peter B. Gilbert, James G. Kublin, Lawrence Corey, David B. Weiner, on behalf of the HVTN 098 Study Team, the NIAID-Funded HIV Vaccine Trials Network
Published 2020-12-01

A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204).

by Gavin J Churchyard, Cecilia Morgan, Elizabeth Adams, John Hural, Barney S Graham, Zoe Moodie, Doug Grove, Glenda Gray, Linda-Gail Bekker, M Juliana McElrath, Georgia D Tomaras, Paul Goepfert, Spyros Kalams, Lindsey R Baden, Michelle Lally, Raphael Dolin, William Blattner, Artur Kalichman, J Peter Figueroa, Jean Pape, Mauro Schechter, Olivier Defawe, Stephen C De Rosa, David C Montefiori, Gary J Nabel, Lawrence Corey, Michael C Keefer, NIAID HIV Vaccine Trials Network
Published 2011-01-01

Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans

by Kelly E. Seaton, Aaron Deal, Xue Han, Shuying S. Li, Ashley Clayton, Jack Heptinstall, Ann Duerr, Mary A. Allen, Xiaoying Shen, Sheetal Sawant, Nicole L. Yates, Paul Spearman, Gavin Churchyard, Paul A. Goepfert, Janine Maenza, Glenda Gray, Giuseppe Pantaleo, Laura Polakowski, Harriet L. Robinson, Shannon Grant, April K. Randhawa, Ying Huang, Cecilia Morgan, Nicole Grunenberg, Shelly Karuna, Peter B. Gilbert, M. Juliana McElrath, Yunda Huang, Georgia D. Tomaras, NIAID HIV Vaccine Trials Network (HVTN) 076, 088, 086, 096, 097, 205 Study Teams
Published 2021-04-01

Vaginal practices among women at risk for HIV acquisition in Soweto, South Africa

by Erica Lazarus, Kennedy Otwombe, Janan Dietrich, Michele P. Andrasik, Cecilia A. Morgan, James G. Kublin, Glenda E. Gray, Abby J. Isaacs, Fatima Laher
Published 2019-06-01

Attracting, equipping and retaining young medical doctors in HIV vaccine science in South Africa

by Danna Flood, Melissa Wallace, Kimberly Bloch, James Kublin, Linda-Gail Bekker
Published 2015-11-01

Antiretroviral Treatment in Resource-Limited Settings 2012

by Ann Duerr, Fredrick L. Altice, Anthony D. Harries, Annette H. Sohn
Published 2012-01-01

Human gut microbiota is associated with HIV-reactive immunoglobulin at baseline and following HIV vaccination.

by Jacob A Cram, Andrew J Fiore-Gartland, Sujatha Srinivasan, Shelly Karuna, Giuseppe Pantaleo, Georgia D Tomaras, David N Fredricks, James G Kublin
Published 2019-01-01

Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses.

by Gemma Hancock, Hongbing Yang, Elisabeth Yorke, Emma Wainwright, Victoria Bourne, Alyse Frisbee, Tamika L Payne, Mark Berrong, Guido Ferrari, Denis Chopera, Tomas Hanke, Beatriz Mothe, Christian Brander, M Juliana McElrath, Andrew McMichael, Nilu Goonetilleke, Georgia D Tomaras, Nicole Frahm, Lucy Dorrell
Published 2015-02-01

A retrospective analysis of incident pregnancy in phase 1 and 2a HIV-1 vaccine study participants does not support concern for adverse pregnancy or birth outcomes

by Lynda Stranix-Chibanda, Chenchen Yu, Margaret Brewinski Isaacs, Mary Allen, Jessica Andriesen, Stephen R. Walsh
Published 2021-08-01

Standardized metrics can reveal region-specific opportunities in community engagement to aid recruitment in HIV prevention trials.

by Gail B Broder, Jonathan P Lucas, Jontraye Davis, Stephaun E Wallace, Nandisile Luthuli, Kagisho Baepanye, Rhonda R White, Marcus Bolton, Cheryl Blanchette, Michele P Andrasik
Published 2020-01-01

Standardized metrics can reveal region-specific opportunities in community engagement to aid recruitment in HIV prevention trials

by Gail B. Broder, Jonathan P. Lucas, Jontraye Davis, Stephaun E. Wallace, Nandisile Luthuli, Kagisho Baepanye, Rhonda R. White, Marcus Bolton, Cheryl Blanchette, Michele P. Andrasik, Douglas S. Krakower
Published 2020-01-01

Ancillary study management systems: a review of needs

by Nelson Elizabeth K, Piehler Britt, Rauch Adam, Ramsay Sarah, Holman Drienna, Asare Smita, Asare Adam, Igra Mark
Published 2013-01-01